Cite
MLA Citation
Clive S. Zent et al.. “A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG‐ACRIN cancer research group (E1908).” American journal of hematology, vol. 91, no. 3, n.d., pp. 308–312. http://access.bl.uk/ark:/81055/vdc_100031417358.0x000034